Nasdaq agrx.

Investor Relations. Agile Therapeutics® is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet needs of today’s women. Our product and product candidates are designed to offer women more freedom and flexibility through additional contraceptive options.PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of ...PRINCETON, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has reorganized and streamlined its executive ...Agile Therapeutics Inc (NASDAQ: AGRX) was in 9 hedge funds' portfolios at the end of September. The all time high for this statistic is 15. AGRX has experienced a decrease in support from the ...Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.

Find the latest press releases from Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. PRINCETON, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Twirla will become available through FPA Women’s ...PRINCETON, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has ...

PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of ...

Find the latest Financials data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.AGRX Earnings Date and Information. Agile Therapeutics last issued its quarterly earnings results on August 9th, 2023. The specialty pharmaceutical company reported ($3.10) earnings per share for the quarter, beating analysts' consensus estimates of ($3.48) by $0.38. The firm had revenue of $5.50 million for the quarter, compared to the ...26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report third quarter 2023 financial ...Sep 28, 2023 · Nasdaq Futures. 15,953.25 ... (NASDAQ:AGRX) to a "buy" rating. Agile Therapeutics is a women's healthcare company that is "dedicated to fulfilling the unmet needs of today's women." Its product ... Find the latest press releases from Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.

Based on analysts offering 12 month price targets for AGRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

Feb 27, 2023 · The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”

Follow. add_box. ... PRINCETON, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Al Altomari, Chairman and Chief ...PRINCETON, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2022 ...The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”Find the latest press releases from Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a partnership with Pandia Health, an online telehealth ...

PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of ...AGRX has an Altman Z-Score of -49.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Agile Therapeutics, Inc. (AGRX) stock, including valuation metrics, financial numbers, share information and more.Agile Therapeutics (NASDAQ:AGRX) and DMK Pharmaceuticals are both small-cap medical companies, but which is the better stock?We will compare the two businesses based on the strength of their valuation, dividends, risk, community ranking, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.PRINCETON, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairperson and Chief Executive Officer Al Altomari and Chief Commercial Officer Amy Welsh will present at the H.C.... Twirla Delivers Second Quarter 2023 Net Revenue of …We closed out the fourth quarter 2021 with a net loss of $23.4 million or $0.20 per share compared to the net loss of $17.6 million or $0.20 per share for the comparable period in 2020. The full ...Find real-time AGRX - Agile Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Find the latest Earnings Report Date for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.

PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of ...

Nov 9, 2023 · PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three and nine months ended ... PRINCETON, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on January 9, 2019 it received final meeting ...November 20, 2023 at 1:14 PM PST. Listen. 1:51. The Nasdaq 100 Stock Index closed at the highest in nearly two years, with tech stocks gaining on high expectations for artificial …In the third quarter of 2023, we generated gross profit of $4.2 million or gross margin of 63% compared to $3.2 million or gross margin of 58% in the second quarter of 2023.4. Agile Therapeutics Inc. (NASDAQ: AGRX) Despite a long string of selling pressure, the last week has become incredibly active. Agile sold off its net operating loss tax benefits earlier this month for $4.7 million, which helped boost things. Meanwhile, the company's Twirla transdermal patch remains a core point of interest for the market.PRINCETON, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2018 ...Nov 14, 2021 · Agile Therapeutics, Inc. (Agile or the Company) (NasdaqCM: NASDAQ: AGRX) is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Agile ... View live Agile Therapeutics, Inc. chart to track its stock's price action. Find market predictions, AGRX financials and market news.PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after ...

Shares of NASDAQ AGRX opened at $2.16 on Friday. The firm has a market capitalization of $5.42 million, a PE ratio of -0.16 and a beta of 1.81. The firm’s 50-day moving average is $1.99 and its ...

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report first quarter 2021 financial results after the market close on Tuesday, May 4, 2021 as ...

Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information. Institutional ... A. The latest price target for Agile Therapeutics ( NASDAQ: AGRX) was reported by Maxim Group on Friday, September 22, 2023. The analyst firm set a price …PRINCETON, N.J., July 18, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Dennis P. Reilly as Chief Financial ...Feb 27, 2023 · The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.” PRINCETON, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2022 ...PRINCETON, N.J., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, announced a positive outcome from today’s meeting of the Bone ...PRINCETON, N.J., March 01, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three and twelve months ended ...PRINCETON, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the ...PRINCETON, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended June 30, 2022 ...The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current trading symbol "AGRX."Agile Therapeutics Inc (NASDAQ:AGRX) shares are down by over 99% in the last year and down almost 72% in the last three months. As of this writing, Agile Therapeutics shares are trading at above $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of more than $15 million.

PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla ...AGRX | Complete Agile Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.PRINCETON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced that it has ...Instagram:https://instagram. west pharmaceuticalbuy or sell disney stockieo etfxhb holdings PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 ...Apr 10, 2023 · The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current trading symbol "AGRX." The reverse stock ... tradovate reviewstop monthly dividend paying mutual funds Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Agile Therapeutics, Inc. (AGRX) NasdaqCM - NasdaqCM Real...AGRX earnings call for the period ending June 30, 2022. Image source: The Motley Fool. Agile Therapeutics ( AGRX 1.60%) Q2 2022 Earnings Call. Aug 11, 2022, 4:30 p.m. ET. nyse mos Oct 21, 2022 · NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 Published. Oct 21, 2022 11:00am EDT. Benzinga Digital Content Studio--News Direct--Contact Details. Find the latest press releases from Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.